SHUBHAM PANT to Head and Neck Neoplasms
This is a "connection" page, showing publications SHUBHAM PANT has written about Head and Neck Neoplasms.
Connection Strength
0.115
-
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies. Clin Cancer Res. 2021 06 01; 27(11):3050-3060.
Score: 0.067
-
PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck. Oral Oncol. 2016 10; 61:31-40.
Score: 0.049